This website uses third-party profiling cookies to provide services in line with the preferences you reveal while browsing the Website. By continuing to browse this Website, you consent to the use of these cookies. If you want to object such processing, please read the instructions described in our Cookie Policy.

Zuzanna Brzosko, George Foot and Anna Perdrix Rosell

Sixfold Bioscience

Brzosko, 28, Foot, 29, and Perdrix Rosell, 27, are developing technology to deliver high doses of medication direct to tumours, rather than affecting the healthy cells of cancer patients. The trio, based at Imperial College London’s start-up incubator, have started lab tests on mice.

Request a Test Drive, a Quote or More Information